Streamly
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Carbon MitigationResiliencyEnergyResourcesBiodiversitySocial Sustainability Tools & FrameworksStrategy
Private CapitalBankingFintechWealth & Investment ManagementInsurance
Content StrategyData & AnalyticsSocial MediaLeadership & CultureMarketing Strategy
Growth StrategyLeadership & CultureTools & MethodologyCybersecurityTelecommunications
Leadership & CultureTools & MethodologyConsumer InsightsStrategy
RenewablesHydrogenBiofuelsEnergy & Battery StorageDecarbonisationInfrastructure & Development
Digital HealthChronic DiseaseAged Care & DisabilityHospital ManagementFunding, Policy & WorkforceLegal & Ethical IssuesBiotech & PharmaHealth Infrastructure
RestaurantsIndustryMenuCulinaryRetailWorkforceOperationsConsumers
Leadership & CultureStrategyDiversity, Equity & InclusionInspiration
Future of WorkLearning & Development Employee ExperienceHR TechLeadership & CultureTalent Acquisition
RailHaulage & Freight DecarbonisationInfrastructure
SustainabilityFinanceMarketingInnovation & TechnologyData & InsightsEnergyHealthcareFoodserviceLeadershipHRTransport & InfrastructureMeetings & EventsBuildings & Real Estate

The pathway to success in biotech

The pathway to success in biotech

0:00
0%
0:00
|
0:00
https://cdn.streamly.video/From_Lab_to_Market_Stories_of_Biotech_e82170a2bb.png
PREVIEW
VaccinesBiotechNew Tech Innovations
David HoeyDavid HoeyChief Executive Officer at Vaxxas

David Hoey is the CEO of Vaxxas, a Brisbane-based biotech company revolutionizing vaccine delivery technology.

With a focus on targeted science, Vaxxas aims to transform how vaccines are administered through their innovative patch technology. This approach enhances immune responses and improves global health outcomes by making vaccines more effective and accessible.

Making psychedelic therapy accessible and affordable
Making psychedelic therapy accessible and affordableDr. Prash Puspanathan
Driving innovation in biotech
Driving innovation in biotechDr. Nina Webster
Why AI is the future of clinical trials
Why AI is the future of clinical trialsSaurabh Jain
How to invest with purpose and profit in the biotech industry
How to invest with purpose and profit in the biotech industry Emerald Scofield
Navigating the pathway to success in biotech
Navigating the pathway to success in biotechRebecca McQualter
The key to a successful capital raise & non-dilutive funding
The key to a successful capital raise & non-dilutive fundingJames Graham
Show more content
Description

Join us for an enlightening interview with David Hoey, CEO of Vaxxas, as he discusses groundbreaking innovations in vaccine delivery technology.

Discover how Vaxxas innovative approach is set to transform vaccine delivery and improve global health outcomes.

Table Of Contents
Success Factors and Technology Development
Future Prospects and Impact
Challenges and Advice for Biotech Innovators
Closing Remarks and Future Outlook
0
Your cart